0001209191-20-063358.txt : 20201214 0001209191-20-063358.hdr.sgml : 20201214 20201214200148 ACCESSION NUMBER: 0001209191-20-063358 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201214 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rodino-Klapac Louise CENTRAL INDEX KEY: 0001836218 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 201387847 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: STE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-12-14 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001836218 Rodino-Klapac Louise 215 FIRST STREET CAMBRIDGE MA 0 1 0 0 Chief Scientific Officer Common Stock 7169 D Stock Option (right to buy) 76.36 2019-04-30 2028-04-30 Common Stock 28875 D Stock Option (right to buy) 145.48 2020-03-04 2029-03-04 Common Stock 2748 D Stock Option (right to buy) 145.48 2020-03-04 2029-03-04 Common Stock 37252 D Stock Option (right to buy) 114.47 2021-02-28 2030-02-28 Common Stock 873 D Stock Option (right to buy) 114.47 2021-02-28 2030-02-28 Common Stock 36627 D Stock Option (right to buy) 114.47 2021-02-28 2030-02-28 Common Stock 25000 D Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter. /s/ Louise Rodino-Klapac 2020-12-14